Comparison of Osteoporosis Disease Management Strategies

This study is ongoing, but not recruiting participants.

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00145080

Purpose

The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.

Condition	Intervention
Osteoporosis	Behavioral: Disease Management Assessment

MedlinePlus related topics: Minerals Osteoporosis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment
Official Title:	Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization

Further study details as provided by Merck:

Primary Outcome Measures:

Bone mineral density screening rates

Secondary Outcome Measures:

Medications adoptions; Medications adherence

Estimated Enrollment:	4685
Study Start Date:	July 2004

Eligibility

Ages Eligible for Study:	50 Years to 64 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Members of the Harvard Pilgrim Health Plan

Exclusion Criteria:

Individuals who are not members of the Harvard Pilgrim Health Plan

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00145080

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

Study ID Numbers:	2005_050
Study First Received:	September 1, 2005
Last Updated:	September 7, 2005
ClinicalTrials.gov Identifier:	NCT00145080
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Musculoskeletal Diseases
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on January 16, 2009